Vol 2013, No 5 (2013)

Table of Contents

Research & Development

AstraZeneca Continues Early-Stage Deal-Making Spree with Alchemia Deal Abstract
Heather Cartwright
Forma Therapeutics Partners with Celgene in its Largest Deal to Date Abstract
Heather Cartwright
Merck & Co. Collaborates with Pfizer and Abide Therapeutics with Aim of Bolstering Diabetes Portfolio Abstract
Heather Cartwright
Concert Pharmaceuticals Snags Celgene as a Partner for its DCE Platform® Abstract
Heather Cartwright
Shire Partners with Nimbus Discovery to Develop Oral Therapies for Lysosomal Storage Disorders Abstract
Heather Cartwright

Licensing

Merck & Co. Out-Licenses Second CNS Programme to Cerecor Abstract
Heather Cartwright

Mergers & Acquisitions

Bayer Boosts Contraceptive Business with US$1.1 B Conceptus Purchase Abstract
Heather Cartwright
Takeda Joins the Dengue Vaccine Race with Inviragen Purchase Abstract
Heather Cartwright
Actavis Agrees US$8.5 B Buyout of Warner Chilcott to Expand Speciality Drug Portfolio Abstract
Heather Cartwright

Joint Venture

Vectura Forays into China by Forming JV with Tianjin KingYork and Zendex Bio Strategy Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.